PDEX: Pro-Dex Inc Broker Consensus Forecast

Corporate company logo of Pro-Dex Inc (PDEX)

Pro-Dex, Inc. (PDEX) specializes in the development of high-precision actuators and tooling for surgery. This chart reflects the price action of the asset, which currently stands at 74.11. The company's profitability is increasing through the mass production of base motors, which optimizes costs. Stable demand for robotic surgery and orthopedic solutions confirms the business's maturity and guarantees the efficient utilization of production capacities.

PDEX Pro-Dex Inc Consensus Target (07/04/2022 - 11/11/2026)

Analytical breakdowns for Pro-Dex Corp (PDEX)

- share price and expert price forecast:
Quote Chart pro-dex.com|PDEX - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Pro-Dex Corp|PDEX - Enterprise Value
- business book valuation details:
Net Asset Value per Share Pro-Dex|PDEX - Company Net Assets|Capitalization to Book Value Ratio pro-dex.com|PDEX - Aggregate Company Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Pro-Dex, Inc.|PDEX - Long-Term Debt to Capital|Current Liabilities to Capital Pro-Dex Inc.|PDEX - Company Aggregate Debts|Debt to Book Value Ratio Pro-Dex Corp|PDEX - Company Long-Term Debts|Short-Term Debt Volume Pro-Dex|Quick Liquidity Indicator pro-dex.com
- earnings and multiples data:
PDEX - Net Profit|Projected Future Earnings Pro-Dex, Inc.|PDEX - Price to Earnings Ratio|Future Price to Earnings Pro-Dex Inc|PDEX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Pro-Dex Corp|PDEX - Operating profit EBITDA|Net earnings per share for the last four quarters Pro-Dex|PDEX - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months pro-dex.com|PDEX - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Pro-Dex, Inc.
General company analysis:pro-dex.com (PDEX)
Original product of Pro-Dex

Pro-Dex, Inc. (PDEX) expansion into the US medical sector requires a constant reassessment of asset values through the lens of the cost of debt. By analyzing the consensus forecast for the security, an investor can identify the weighted average of agency target prices, which allows for an assessment of how quickly market expectations are adapting to the scaling of instrument production and determines the fair potential for capital growth.

Competing companies

ISRG: Forecast Levels Chart|Analyst Consensus Forecast DHR (Danaher)|BDX: Broker Consensus Forecast|STERIS Corporation - Analyst Consensus Forecast|Average Forecast Price West Pharma Corp|BAX (Baxter International) - Consensus Target|Broker Consensus Forecast MASI|Price Target Chart Stevanato Group|Consensus Target Teleflex Inc. (TFX)|Analyst Consensus Forecast MMSI|NVST - Average Forecast Price|Analyst Consensus Forecast ICUI (ICU Medical, Inc.)|XRAY: Broker Consensus Forecast|LeMaitre Vascular - Analyst Consensus Forecast|Analyst Median Target AtriCure Inc ATRC|STAA: Analyst Consensus Forecast|Consensus Target ChromaDex Corp.|ZIMV (ZimVie Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast angiodynamics.com|Price Target Chart Cerus (CERS)|Price Target Chart TKNO (Alpha Teknova)|Monogram Technologies Inc - Consensus Target|Fair Value Consensus STSS|InfuSystem Inc - Analyst Consensus Forecast|Analyst Median Target utahmed.com UTMD|korumedical.com (KRMD) - Price Target Chart|Broker Consensus Forecast NYXH|Price Target Chart Microbot Medical Inc|Zentek Corp (ZTEK) - Analyst Median Target|Consensus Target ELUT (Elutia Inc.)|Analyst Forecast Prices MLSS|Price Target Chart NEXGEL NXGL|Fair Value Consensus RVP|HBIO: Consensus Target|FEMY - Analyst Consensus Forecast|meihuamed.com (MHUA) - Price Target Chart|Consensus Target Predictive Oncology Inc.|CJMB (Callan JMB Inc.) - Analyst Consensus Forecast|Average Forecast Price Atrion Corp. ATRI|Price Target Chart NeuroMetrix Corp (NURO)